Wolverine Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History

Wolverine Trading’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$21.9K	Buy	+15,400	New	+$15.9K	﹤0.01%	5530
2024 Q2	–	Sell	-52,700	Closed	-$459K	–	4838
2024 Q1	$459K	Buy	+52,700	New	+$639K	﹤0.01%	2929
2022 Q1	–	Sell	-15,900	Closed	-$186K	–	5892
2021 Q4	$186K	Buy	15,900 +2,100	+15%	+$25.8K	﹤0.01%	4763
2021 Q3	$183K	Buy	13,800 +2,900	+27%	+$37.5K	﹤0.01%	5412
2021 Q2	$139K	Buy	+10,900	New	+$125K	﹤0.01%	5238
2018 Q4	–	Sell	-23,044	Closed	-$356K	–	4880
2018 Q3	$356K	Sell	23,044 -1,552	-6%	-$24.5K	﹤0.01%	3516
2018 Q2	$318K	Hold	24,596	–	–	﹤0.01%	3690
2018 Q1	$318K	Buy	+24,596	New	+$307K	﹤0.01%	3690
2017 Q4	–	Sell	-21,134	Closed	-$279K	–	5179
2017 Q3	$279K	Buy	+21,134	New	+$291K	﹤0.01%	3358
2016 Q4	–	Sell	-19,701	Closed	-$254K	–	4759
2016 Q3	$254K	Sell	19,701 -4,537	-19%	-$53K	﹤0.01%	3471
2016 Q2	$263K	Buy	+24,238	New	+$237K	﹤0.01%	2961

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wolverine Trading's IRWD Position: Q1 2025 in Review

Wolverine Trading sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 12,502 shares — an estimated $54.8K sold.

Wolverine Trading first reported a position in IRWD in Q3 2017 and held it in 11 quarters. The position peaked at $330K in Q1 2021. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

Wolverine Trading reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Wolverine Trading sold 12,502 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $54.8K.
Wolverine Trading first reported a position in Ironwood Pharmaceuticals in Q3 2017 and held it in 11 quarters.
Wolverine Trading's Ironwood Pharmaceuticals position peaked at $330K in Q1 2021.
200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.